| 789208 | THERANOSTICS | Light on osteoarthritic joint: from bench to bed | 2022-01-01 | 10.7150/thno.64340 | Zhou Yingying, Ni Junguo, Wen Chunyi, Lai Puxiang | 
         
      | 789207 | THERANOSTICS | Evans blue-modified radiolabeled fibroblast activation protein inhibitor as long-acting cancer therapeutics | 2022-01-01 | 10.7150/thno.68182 | Wen Xuejun, Xu Pengfei, Shi Mengqi, Liu Jia, Zeng Xinying, Zhang Yiren, Shi Changrong, Li Jingchao, Guo Zhide, Zhang Xianzhong, Khong Pek-Lan, Chen Xiaoyuan | 
         
      | 789206 | THERANOSTICS | Targeting regulated cell death in tumor nanomedicines | 2022-01-01 | 10.7150/thno.67932 | Zeng Qinghu, Ma Xiangyi, Song Yangmeihui, Chen Qiqing, Jiao Qiuling, Zhou Liqiang | 
         
      | 789205 | THERANOSTICS | Tumor-specific activatable biopolymer nanoparticles stabilized by hydroxyethyl starch prodrug for self-amplified cooperative cancer therapy | 2022-01-01 | 10.7150/thno.67572 | Xiong Yuxuan, Wang Zibing, Wang Qiang, Deng Qingyuan, Chen Jitang, Wei Jianshuang, Yang Xiaoquan, Yang Xiangliang, Li Zifu | 
         
      | 789204 | THERANOSTICS | HDAC6 inhibition reverses long-term doxorubicin-induced cognitive dysfunction by restoring microglia homeostasis and synaptic integrity | 2022-01-01 | 10.7150/thno.67410 | McAlpin Blake R, Mahalingam Rajasekaran, Singh Anand K, Dharmaraj Shruti, Chrisikos Taylor T, Boukelmoune Nabila, Kavelaars Annemieke, Heijnen Cobi J | 
         
      | 789203 | THERANOSTICS | Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle | 2022-01-01 | 10.7150/thno.67375 | Huang Yue, Hsu Jessica C., Koo Hyun, Cormode David P. | 
         
      | 789202 | THERANOSTICS | Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy | 2022-01-01 | 10.7150/thno.67300 | Ji Bin, Wei Minjie, Yang Bin | 
         
      | 789201 | THERANOSTICS | Tailoring noble metal nanoparticle designs to enable sensitive lateral flow immunoassay | 2022-01-01 | 10.7150/thno.67184 | Chen Xirui, Ding Lu, Huang Xiaolin, Xiong Yonghua | 
         
      | 789200 | THERANOSTICS | Resveratrol ameliorates polycystic ovary syndrome via transzonal projections within oocyte-granulosa cell communication | 2022-01-01 | 10.7150/thno.67167 | Chen Mingyue, He Chengyong, Zhu Kongyang, Chen Zihan, Meng Zixiao, Jiang Xiaoming, Cai Jiali, Yang Chunyan, Zuo Zhenghong | 
         
      | 789199 | THERANOSTICS | FcγRIIB potentiates differentiation of myeloid-derived suppressor cells to mediate tumor immunoescape | 2022-01-01 | 10.7150/thno.66575 | Wu Lei, Xu Yanquan, Zhao Huakan, Zhou Yu, Chen Yu, Yang Shuai, Lei Juan, Zhang Jiangang, Wang Jingchun, Wu Yongzhong, Li Yongsheng |